SCHEMBL4766042

SCHEMBL4766042

O=c1c([N+](=O)[O-])c(C=Cc2cnn(Cc3ccccc3F)c2)n(Cc2ccoc2)c(=O)n1Cc1ccoc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
MAPT P10636 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
PKM P14618 2/20 0.35
ADORA2A P29274 1/20 0.35
ADORA2B P29275 1/20 0.35
ADORA1 P30542 1/20 0.35
SCD O00767 2/20 0.32
SCD5 Q86SK9 2/20 0.32
GAA P10253 1/20 0.32
TP53 P04637 1/20 0.31
PKLR P30613 1/20 0.31
HSPD1 P10809 1/20 0.31
HSPE1 P61604 1/20 0.31
HDAC2 Q92769 1/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
TAS2R8 Q9NYW2 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766036 1.00 ALDH1A1 (0.35) ALDH1A1MAPTL3MBTL1PKMADORA2A
SCHEMBL4770647 0.95 ADORA2A (0.33) ALDH1A1MAPTL3MBTL1PKMADORA2A
SCHEMBL4770638 0.95 ADORA2A (0.33) ALDH1A1MAPTL3MBTL1PKMADORA2A
SCHEMBL4794085 0.93 MAPT (0.38) ALDH1A1MAPTL3MBTL1ADORA2AADORA2B
SCHEMBL4794079 0.93 MAPT (0.38) ALDH1A1MAPTL3MBTL1ADORA2AADORA2B
SCHEMBL4767385 0.91 ADORA2B (0.38) ALDH1A1ADORA2AADORA2BADORA1SCD5
SCHEMBL4767375 0.91 ADORA2B (0.38) ALDH1A1ADORA2AADORA2BADORA1SCD5
SCHEMBL4764053 0.90 ALDH1A1 (0.41) ALDH1A1MAPTL3MBTL1PKMADORA2A
SCHEMBL4762591 0.88 MAPT (0.37) ALDH1A1MAPTL3MBTL1PKMADORA2A
SCHEMBL4762596 0.88 MAPT (0.37) ALDH1A1MAPTL3MBTL1PKMADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed